Chronotropic response in heart failure: clinical, structural, and metabolic predictors and long-term mortality

Noémie Bélanger1,2, Silav Zeid1,2,3, Alexander Gieswinkel1,2,4

  • 1Preventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg University, Langenbeckstr. 1, Mainz 55131, Germany.

Insights

Chronotropic incompetence (CI) is a strong predictor of poor outcomes in heart failure (HF). New definitions and determinants, including metabolic factors, highlight CI

Area of Science:

  • Cardiology and Exercise Physiology
  • Heart Failure Research
  • Metabolic Syndrome and Cardiovascular Disease

Background:

  • Chronotropic incompetence (CI) is common in heart failure (HF) but lacks precise definition.
  • Understanding CI determinants and its impact on clinical outcomes is crucial for risk stratification in HF patients.

Purpose of the Study:

  • To refine the definition of chronotropic incompetence (CI) in heart failure (HF).
  • To identify clinical determinants associated with CI.
  • To evaluate the relationship between CI and adverse clinical outcomes in HF.

Main Methods:

  • Analysis of data from the MyoVasc study (NCT04064450) including deep clinical phenotyping and cardiopulmonary exercise testing (CPET).
  • Exclusion of subjects with a respiratory exchange ratio < 1.0.
  • Operationalization of CI using continuous predicted heart rate reserve (pHRR) and derivation of a new reference range from a healthy subsample; assessment of determinants and outcomes using stepwise regression and Cox regressions, respectively.

Main Results:

  • The study included 880 subjects, with 64.7% identified as CI using the traditional 80% threshold.
  • A new definition of CI was established as pHRR < 56.4%, with determinants including peak oxygen uptake (VO2), beta-blockers, age, sex, smoking, CPET protocol, HF severity, C-peptide, and fatty liver.
  • CI independently predicted all-cause death (HR 1.77), cardiac death (HR 1.74), and worsening of HF (HR 1.39).

Conclusions:

  • Chronotropic incompetence (CI) is a significant independent predictor of mortality and morbidity in heart failure (HF).
  • The association of CI with metabolic factors like hyperinsulinemia and abnormal liver function suggests a link between metabolism and exercise response.
  • These findings underscore the clinical relevance of impaired exercise response in HF and its utility in risk stratification.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...